AMP-activated protein kinase: A potential player in Alzheimer's disease

Journal of Neurochemistry

Volumn 118, Issue 4, 2011, Pages 460-474

  Salminen, Antero ^a,b   Kaarniranta, Kai ^a,b   Haapasalo, Annakaisa ^a,b   Soininen, Hilkka ^a,b   Hiltunen, Mikko ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

aging; Alzheimer's disease; AMPK; autophagy; inflammation; tauopathy

Indexed keywords

CALCIUM ION; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEPTIN; METFORMIN; NATURAL PRODUCT; PHOSPHOPROTEIN PHOSPHATASE 2; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE 2C ALPHA; RESVERATROL; SIRTUIN 1; TAU PROTEIN; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG;

ACETYLATION; ALZHEIMER DISEASE; AUTOPHAGY; BIOGENESIS; CALCIUM BALANCE; CALCIUM HOMEOSTASIS; CELL POLARITY; CELL PROLIFERATION; CHOLESTEROL METABOLISM; DRUG ACTIVITY; DRUG EFFICACY; ENDOPLASMIC RETICULUM; ENERGY METABOLISM; ENERGY YIELD; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; LYSOSOME; NEUROPROTECTION; NONHUMAN; OLIGOMERIZATION; PATHOGENESIS; PHAGOCYTOSIS; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PYRAMIDAL NERVE CELL; REVIEW; SIGNAL TRANSDUCTION; TAUOPATHY; UPREGULATION;

ALZHEIMER DISEASE; AMP-ACTIVATED PROTEIN KINASES; AMYLOID; ANIMALS; AUTOPHAGY; CALCIUM; ENZYME ACTIVATION; HUMANS; INFLAMMATION; LEPTIN; METFORMIN; NEURONS; PHOSPHORYLATION; TAU PROTEINS;

EID: 79960566233     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07331.x     Document Type: Review

References (175)

1. Aggarwal B. B., (2010) Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu. Rev. Nutr. 30, 173-1799.
2. Alonso A. D., Zaidi T., Novak M., Grundke-Iqbal I., and, Iqbal K., (2001) Hyperphosphorylation induces self-assembly of Ï? into tangles of paired helical filaments/straight filaments. Proc. Natl Acad. Sci. USA 98, 6923-6928. (Pubitemid 32538318)
3. Altarejos J. Y., and, Montminy M., (2011) CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat. Rev. Mol. Cell Biol. 12, 141-151.
4. Ansari M. A., Abdul H. M., Joshi G., Opii W. O., and, Butterfield D. A., (2009) Protective effect of quercetin in primary neurons against Aβ(1-42): relevance to Alzheimer's disease. J. Nutr. Biochem. 20, 269-275.
5. Arendt T., Holzer M., Fruth R., Bruckner M. K., and, Gärtner U., (1995) Paired helical filament-like phosphorylation of tau, deposition of β/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A. Neuroscience 69, 691-698.
6. Arstila A. U., and, Trump B. F., (1968) Studies on cellular autophagocytosis. The formation of autophagic vacuoles in the liver after glucagon administration. Am. J. Pathol. 53, 687-733.
7. Attems J., and, Jellinger K. A., (2004) Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology-a pilot study. Acta Neuropathol. 107, 83-90. (Pubitemid 38159295)
8. Barnes A. P., Lilley B. N., Pan Y. A., Plummer L. J., Powell A. W., Raines A. N., Sanes J. R., and, Polleux F., (2007) LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons. Cell 129, 549-563. (Pubitemid 46660970)
9. Beeri M. S., Schmeidler J., Silverman J. M., Gandy S., Wysocki M., Hannigan C. M., Purohit D. P., Lesser G., Grossman H. T., and, Haroutunian V., (2008) Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology. Neurology 71, 750-757.
10. Bergeron M., Yu A. Y., Solway K. E., Semenza G. L., and, Sharp F. R., (1999) Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur. J. Neurosci. 11, 4159-4170. (Pubitemid 30009246)
11. Bhat N. R., (2010) Linking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators. J. Neurochem. 115, 551-562.
12. Bojarski L., Herms J., and, Kuznicki J., (2008) Calcium dysregulation in Alzheimer's disease. Neurochem. Int. 52, 621-633.
13. Boland B., Kumar A., Lee S., Platt F. M., Wegiel J., Yu W. H., and, Nixon R. A., (2008) Autophagy induction and autophagosomes clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J. Neurosci. 28, 6926-6937.
14. Boland B., Smith D. A., Mooney D., Jung S. S., Walsh D. M., and, Platt F. M., (2010) Macroautophagy is not directly involved in the metabolism of amyloid precursor protein. J. Biol. Chem. 285, 37415-37426.
15. Bosco D., Fava A., Plastino M., Montalcini T., and, Pujia A., (2011) Possible implications in insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis. J. Cell Mol. Med. Published Online doi:.
16. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., and, Hof P. R., (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Rev. 33, 95-130.
17. Burgess B. L., Parkinson P. F., Racke M. M., et al. (2008) ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo. J. Lipid Res. 49, 1254-1267.
18. Canto C., and, Auwerx J., (2010) AMP-activated protein kinase and its downstream transcriptional pathways. Cell. Mol. Life Sci. 67, 3407-3423.
19. Canto C., Gerhart-Hines Z., Feige J. N., Lagouge M., Noriega L., Milne J. C., Elliott P. J., Puigserver P., and, Auwerx J., (2009) AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056-1060.
20. Carling D., Sanders M. J., and, Woods A., (2008) The regulation of AMP-activated protein kinase by upstream kinases. Int. J. Obes. 32, S55-S59.
21. Cataldo A. M., Hamilton D. J., Barnett J. L., Paskevich P. A., and, Nixon R. A., (1996) Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J. Neurosci. 16, 186-199. (Pubitemid 26010711)
22. Chen Y., Zhou K., Wang R., et al. (2009) Antidiabetic drug metformin (Glucophage) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription. Proc. Natl Acad. Sci. USA 106, 3907-3912.
23. Chong Z. Z., and, Maiese K., (2008) Enhanced tolerance against early and late apoptotic oxidative stress in mammalian neurons through nicotinamidase and sirtuin mediated pathways. Curr. Neurovasc. Res. 5, 159-170.
24. Concannon C. G., Tuffy L. P., Weisova P., Bonner H. P., Davila D., Bonner C., Devocelle M. C., Strasser A., Ward M. W., and, Prehn J. H. M., (2010) AMP kinase-mediated activation of the BH3-only protein Bim couples energy depletion to stress-induced apoptosis. J. Cell Biol. 189, 83-94.
25. Culmsee C., Monning J., Kemp B. E., and, Mattson M. P., (2001) AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J. Mol. Neurosci. 17, 45-58. (Pubitemid 32928285)
26. Curtis R., O'Connor G., and, DiStefano P. S., (2006) Aging networks in Caenorhabditis elegans: AMP-activated protein kinase (aak-2) links multiple aging and metabolism pathways. Aging Cell 5, 119-126. (Pubitemid 44056503)
27. Cutler R. G., Kelly J., Storie K., Pedersen W. A., Tammara A., Hatanpaa K., Troncoso J. C., and, Mattson M. P., (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl Acad. Sci. USA 101, 2070-2075. (Pubitemid 38229016)
28. Dagon Y., Avraham Y., Magen I., Gertler A., Ben-Hur T., and, Berry E. M., (2005) Nutritional status, cognition, and survival. A new role for leptin and AMP kinase. J. Biol. Chem. 280, 42142-42148. (Pubitemid 43023183)
29. Dardeno T. A., Chou S. H., Moon H. S., Chamberland J. P., Fiorenza C. G., and, Mantzoros C. S., (2010) Leptin in human physiology and therapeutics. Front. Neuroendocrinol. 31, 377-393.
30. Dasgupta B., and, Milbrandt J., (2007) Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl Acad. Sci. USA 104, 7217-7222. (Pubitemid 47186035)
31. Davies S. P., Helps N. R., Cohen P. T. W., and, Hardie D. G., (1995) 5'-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2Cα and native bovine protein phosphatase-2Ac. FEBS Lett. 377, 421-425. (Pubitemid 26027159)
32. Dong Y., Zhang M., Liang B., Xie Z., Zhao Z., Asfa S., Choi H. C., and, Zou M. H., (2010) Reduction of AMP-activated protein kinase α2 increases endoplasmic reticulum stress and atherosclerosis in vivo. Circulation 121, 792-803.
33. Donmez G., Wang D., Cohen D. E., and, Guarente L., (2010) SIRT1 suppresses β-amyloid production by activating the α-secretase gene ADAM10. Cell 142, 320-332.
34. Eskelinen E.-L., and, Saftig P., (2009) Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim. Biophys. Acta 1793, 664-673.
35. Ewart M. A., and, Kennedy S., (2011) AMPK and vasculoprotection. Pharmacol. Ther. Published Online doi:.
36. Flicker L., (2010) Modifiable lifestyle risk factors for Alzheimer's disease. J. Alzheimers Dis. 20, 803-811.
37. Fogarty S., and, Hardie D. G., (2010) Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim. Biophys. Acta 1804, 581-591.
38. Frisardi V., Solfrizzi V., Seripa D., Capurso C., Santamato A., Sancarlo D., Vendemiale G., Pilotto A., and, Panza F., (2010) Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res. Rev. 9, 399-417.
39. Frolich L., Blum-Degen D., Bernstein H. G., et al. (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J. Neural Transm. 105, 423-438. (Pubitemid 28365027)
40. Galindo M. F., Ikuta I., Zhu X., Casadesus G., and, Jordan J., (2010) Mitochondrial biology in Alzheimer's disease pathogenesis. J. Neurochem. 114, 933-945.
41. Giri S., Nath N., Smith B., Viollet B., Singh A. K., and, Singh I., (2004) 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase. J. Neurosci. 24, 479-487. (Pubitemid 38112379)
42. Gong C. X., Singh T. J., Grundke-Iqbal I., and, Iqbal K., (1994) Alzheimer's disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase-2B (calcineurin). J. Neurochem. 62, 803-806. (Pubitemid 24041353)
43. Greco S. J., Sarkar S., Johnston J. M., and, Tezapsidis N., (2009a) Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells. Biochem. Biophys. Res. Commun. 380, 98-104.
44. Greco S. J., Sarkar S., Casadesus G., Zhu X., Smith M. A., Ashford J. W., Johnston J. M., and, Tezapsidis N., (2009b) Leptin inhibits glycogen synthase kinase-3β to prevent tau phosphorylation in neuronal cells. Neurosci. Lett. 455, 191-194.
45. Greco S. J., Bryan K. J., Sarkar S., Zhu X., Smith M. A., Ashford J. W., Johnston J. M., Tezapsidis N., and, Casadesus G., (2010) Leptin reduces pathology and improves memory in a transgenic mouse models of Alzheimer's disease. J. Alzheimers Dis. 19, 1155-1167.
46. Greer E. L., Oskoui P. R., Banko M. R., Maniar J. M., Gygi M. P., Gygi S. P., and, Brunet A., (2007) The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem. 282, 30107-30119. (Pubitemid 350035296)
47. Hamaguchi T., Ono K., and, Yamada M., (2010) Curcumin and Alzheimer's disease. CNS Neurosci. Ther. 16, 285-297.
48. Hannun Y. A., and, Luberto C., (2000) Ceramide in the eukaryotic stress response. Trends Cell Biol. 10, 73-80. (Pubitemid 30084778)
49. Hardie D. G., (2008) AMPK: a key regulator of energy balance in the single cell and the whole organism. Int. J. Obes. (Lond) 32, S7-S12.
50. 2+/calmodulin-dependent protein kinase II and protein kinase C. J. Biol. Chem. 264, 16524-16529. (Pubitemid 19243543)
51. Haughey N. J., Bandaru V. V. R., Bae M., and, Mattson M. P., (2010) Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis. Biochim. Biophys. Acta 1801, 878-886.
52. Hawley S. A., Pan D. A., Mustard K. J., Ross L., Bain J., Edelman A. M., Frenguelli B. G., and, Hardie D. G., (2005) Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2, 9-19. (Pubitemid 43239821)
53. Heneka M. T., and, O'Banion M. K., (2007) Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 184, 69-91. (Pubitemid 46365992)
54. Hotamisligil G. S., (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900-917.
55. Hoyer-Hansen M., and, Jäättelä M., (2007) AMP-activated protein kinase. A universal regulator of autophagy? Autophagy 3, 381-383. (Pubitemid 46986350)
56. Hui A. S., Bauer A. L., Striet J. B., Schnell P. O., and, Czyzyk-Krzeska M. F., (2006) Calcium signaling stimulates translation of HIF-alpha during hypoxia. FASEB J. 20, 466-475. (Pubitemid 44933323)
57. Hwang J. T., Kwon D. Y., and, Yoon S. H., (2009) AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. N. Biotechnol. 26, 17-22.
58. Iqbal K., and, Grundke-Iqbal I., (1991) Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease. Mol. Neurobiol. 5, 399-410.
59. Jansen M., Klooster J. P. T., Offerhaus G. J., and, Clevers H., (2009) LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism. Physiol. Rev. 89, 777-798.
60. Jeong H. W., Hsu K. C., Lee J. W., Ham M., Huh J. Y., Shin H. J., Kim W. S., and, Kim J. B., (2009) Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am. J. Physiol. Endocrinol. Metab. 296, E955-E964.
61. Julien C., Tremblay C., Emond V., Lebbadi M., Salem Jr N., Bennett D. A., and, Calon F., (2009) Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J. Neuropathol. Exp. Neurol. 68, 48-58.
62. Jung S. N., Yang W. K., Kim J., et al. (2008) Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. Carcinogenesis 29, 713-721. (Pubitemid 351494158)
63. Karuppagounder S. S., Pinto J. T., Xu H., Chen H. L., Beal M. F., and, Gibson G. E., (2009) Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem. Int. 54, 111-118.
64. Khachaturian Z. S., (1994) Calcium hypothesis of Alzheimer's disease and brain aging. Ann. NY Acad. Sci. 747, 1-11.
65. Kickstein E., Krauss S., Thornhill P., et al. (2010) Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. Proc. Natl Acad. Sci. USA 107, 21830-21835.
66. Kim T., Davis J., Zhang A. J., He X., and, Mathews S. T., (2009) Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochem. Biophys. Res. Commun. 388, 377-382.
67. Kim J., Lee H. J., and, Lee K. W., (2010) Naturally occurring phytochemicals for the prevention of Alzheimer's disease. J. Neurochem. 112, 1415-1430.
68. Kim J., Kundu M., Viollet B., and, Guan K. L., (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132-141.
69. Ko H. J., Zhang Z., Jung D. Y., Jun J. Y., Ma Z., Jones K. E., Chan S. Y., and, Kim J. K., (2009) Nutrient stress activates inflammation and reduces glucose metabolism by suppressing AMP-activated protein kinase in the heart. Diabetes 58, 2536-2546.
70. Kuhn P. H., Wang H., Dislich B., Colombo A., Zeitschel U., Ellwart J. W., Kremmer E., Rossner S., and, Lichtenthaler S. F., (2010) ADAM10 is the physiologically relevant, constitutive α-secretase of the amyloid precursor protein in primary neurons. EMBO J. 29, 3020-3032.
71. Kulkarni S. K., and, Dhir A., (2010) Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother. Res. 24, 317-324.
72. Labuzek K., Liber S., Gabryel B., Adamczyk J., and, Okopien B., (2010) Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in AMPK-dependent manner in rat primary microglia. Naunyn-Schmied. Arch. Pharmacol. 381, 171-186.
73. LaFerla F. M., (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 3, 862-872.
74. Lage R., Dieguez C., Vidal-Puig A., and, Lopez M., (2008) AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol. Med. 14, 539-549.
75. Lee M., Hwang J. T., Lee H. J., Jung S. N., Kang I., Chi S. G., Kim S. S., and, Ha J., (2003) AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. J. Biol. Chem. 278, 39653-39661. (Pubitemid 37248526)
76. Lee I. H., Cao L., Mostoslavsky R., Lombard D. B., Liu J., Bruns N. E., Tsokos M., Alt F. W., and, Finkel T., (2008) A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl Acad. Sci. USA 105, 3374-3379. (Pubitemid 351723560)
77. Lee J. Y., Jeon B. T., Shin H. J., Lee D. H., Han J. Y., Kim H. J., Kang S. S., Cho G. J., Choi W. S., and, Roh G. S., (2009) Temporal expression of AMP-activated protein kinase activation during the kainic acid-induced hippocampal cell death. J. Neural. Transm. 116, 33-40.
78. Lee J. H., Yu W. H., Kumar A., et al. (2010a) Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141, 1146-1158.
79. Lee J. W., Park S., Takahashi Y., and, Wang H. G., (2010b) The association of AMPK with ULK1 regulates autophagy. PLoS ONE 5, e15394.
80. Levine B., and, Kroemer G., (2008) Autophagy in the pathogenesis of disease. Cell 132, 27-42.
81. Li J., and, McCullough L. D., (2010) Effects of AMP-activated protein kinase in cerebral ischemia. J. Cereb. Blood Flow Metab. 30, 480-492.
82. Li J., Zeng Z., Viollet B., Ronnett G. V., and, McCullough L. D., (2007) Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke. Stroke 38, 2992-2999. (Pubitemid 350035695)
83. Li X. N., Song J., Zhang L., et al. (2009) Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin. Diabetes 58, 2246-2257.
84. Li J., Benashski S. E., Venna V. R., and, McCullough L. D., (2010a) Effects of metformin in experimental stroke. Stroke 41, 2645-2652.
85. Li D., Wang D., Wang Y., Ling W., Feng X., and, Xia M., (2010b) Adenosine monophosphate-activated protein kinase induces cholesterol efflux from macrophage-derived foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice. J. Biol. Chem. 285, 33499-33509.
86. Li D., Zhang Y., Ma J., Ling W., and, Xia M., (2010c) Adenosine monophosphate activated protein kinase regulates ABCG1-mediated oxysterols efflux from endothelial cells and protects against hypercholesterolemia-induced endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 30, 1354-1362.
87. Lieb W., Beiser A. S., Vasan R. S., et al. (2009) Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 302, 2565-2572.
88. Lim C. T., Kola B., and, Korbonits M., (2010) AMPK as a mediator of hormonal signalling. J. Mol. Endocrinol. 44, 87-97.
89. Lin L., Hron J. D., and, Peng S. L., (2004) Regulation of NF-Î?B, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21, 203-213. (Pubitemid 39094050)
90. Liu Y., Liu F., Iqbal K., Grundke-Iqbal I., and, Gong C. X., (2008) Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett. 582, 359-364.
91. Liu F., Benashski S. E., Persky R., Xu Y., Li J., and, McCullough L. D., (2011) Age-related changes in AMP-activated protein kinase after stroke. Age Published Online doi:.
92. Love S., Miners S., Palmer J., Chalmers K., and, Kehoe P., (2009) Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy. Front. Biosci. 14, 4778-4792.
93. Lu J., Wu D. M., Zheng Y. L., Hu B., Zhang Z. F., Shan Q., Zheng Z. H., Liu C. M., and, Wang Y. J., (2010) Quercetin activates AMP-activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol-induced neurotoxicity. J. Pathol. 222, 199-212.
94. Mair W., Morantte I., Rodrigues A. P. C., Manning G., Montminy M., Shaw R. J., and, Dillin A., (2011) Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB. Nature 470, 404-408.
95. Mandelkow E., von Bergen M., Biernat J., and, Mandelkow E. M., (2007) Structural principles of tau and the paired helical filaments of Alzheimer's disease. Brain Pathol. 17, 83-90.
96. Mantovani J., and, Roy R., (2011) Re-evaluating the general(ized) roles of AMPK in cellular metabolism. FEBS Lett. 585, 967-972.
97. Martins I. J., Berger T., Sharman M. J., Verdile G., Fuller S. J., and, Martins R. N., (2009) Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease. J. Neurochem. 111, 1275-1308.
98. Marwarha G., Dasari B., Prasanthi J. R. P., Schommer J., and, Ghribi O., (2010) Leptin reduces the accumulation of Aβ and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices. J. Alzheimers Dis. 19, 1007-1019.
99. Mazure N. M., and, Pouyssegur J., (2010) Hypoxia-induced autophagy: cell death or cell survival? Curr. Opin. Cell Biol. 22, 177-180.
100. McCullough L. D., Zeng Z., Li H., Landree L. E., McFadden J., and, Ronnett G. V., (2005) Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J. Biol. Chem. 280, 20493-20502. (Pubitemid 40776749)
101. Merlo S., Spampinato S., Canonico P. L., Copani A., and, Sortino M. A., (2010) Alzheimer's disease: brain expression of a metabolic disorder? Trends Endocrinol Metab. 21, 537-544.
102. Min S. W., Cho S. H., Zhou Y., et al. (2010) Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67, 953-966.
103. Moloney A. M., Griffin R. J., Timmons S., O'Connor R., Ravid R., and, O'Neill C., (2010) Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signaling. Neurobiol. Aging 31, 224-243.
104. de la Monte S. M., (2009) Insulin resistance and Alzheimer's disease. BMB Rep. 42, 475-481.
105. Mosconi L., Pupi A., and, De Leon M. J., (2008) Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann. NY Acad. Sci. 1147, 180-195.
106. Murray M. E., Knopman D. S., and, Dickson D. W., (2007) Vascular dementia: clinical, neuroradiological and neuropathologic aspects. Paminerva Med. 49, 197-2007.
107. 2+/calmodulin-dependent protein kinase kinase β in rat central nervous system. Neurosci. Res. 39, 175-188. (Pubitemid 32153894)
108. Neely K. M., Green K. N., and, LaFerla F. M., (2011) Presenilin is necessary for efficient proteolysis through the autophagy-lysosomal system in a Î?-secretase-independent manner. J. Neurosci. 31, 2781-2791.
109. Nixon R. A., and, Yang D. S., (2011) Autophagy failure in Alzheimer's disease-locating the primary defect. Neurobiol. Dis. 43, 38-45.
110. Ogunshola O. O., and, Antoniou X., (2009) Contribution of hypoxia to Alzheimer's disease: is HIF-1α a mediator of neurodegeneration? Cell. Mol. Life Sci. 66, 3555-3563.
111. Olivieri O., Martinelli N., Bassi A., Trabetti E., Girelli D., Pizzolo F., Friso S., Pignatti P. F., and, Corrocher R., (2007) ApoEÎμ2/ Îμ3/Îμ4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome. Clin. Exp. Med. 7, 164-172.
112. Panza F., Frisardi V., Capurso C., et al. (2010) Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J. Alzheimers Dis. 21, 691-724.
113. Parks A. L., and, Curtis D., (2007) Presenilin diversifies its portfolio. Trends Genet. 23, 140-150. (Pubitemid 46275145)
114. Patel J. R., and, Brewer G. J., (2003) Age-related changes in neuronal glucose uptake in response to glutamate and β-amyloid. J. Neurosci. Res. 72, 527-536. (Pubitemid 36523427)
115. Patzke H., and, Tsai L. H., (2002) Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29. J. Biol. Chem. 277, 8054-8060. (Pubitemid 34968258)
116. Poels J., Spasic M. R., Callaerts P., and, Norga K. K., (2009) Expanding roles for AMP-activated protein kinase in neuronal survival and autophagy. Bioessays 31, 944-952.
117. Qiang W., Weiqiang K., Qing Z., Pengju Z., and, Yi L., (2007) Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKα. Exp. Mol. Med. 39, 535-543. (Pubitemid 47443868)
118. Querfurth H. W., and, LaFerla F. M., (2010) Alzheimer's disease. N. Engl. J. Med. 362, 329-344.
119. Ravikumar B., Sarkar S., Divies J. E., et al. (2010) Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev. 90, 1383-1435.
120. Ren J., Pulakat L., Whaley-Connell A., and, Sowers J. R., (2010) Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J. Mol. Med. 88, 993-1001.
121. Reznick R. M., Zong H., Li J., et al. (2007) Aging-associated reductions in AMPK-activated protein kinase activity and mitochondrial biogenesis. Cell Metab. 5, 151-156. (Pubitemid 46172924)
122. Rivera E. J., Goldin A., Fulmer N., Tavares R., Wands J. R., and, de la Monte S. M., (2005) Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J. Alzheimer's Dis. 8, 247-268.
123. Ronnett G. V., Ramamurthy S., Kleman A. M., Landree L. E., and, Aja S., (2009) AMPK in the brain: its roles in energy balance and neuroprotection. J. Neurochem. 109 (Suppl. 1), 17-23.
124. Ruderman N. B., Keller C., Richard A. M., et al. (2006) Interleukin-6 regulation of AMPK-activated protein kinase. Potential role in the systemic response to exercise and prevention of the metabolic syndrome. Diabetes 55 (Suppl. 2), S48-S54. (Pubitemid 44927032)
125. Salminen A., and, Kaarniranta K., (2009a) Regulation of the aging process by autophagy. Trends Mol. Med. 15, 217-224.
126. Salminen A., and, Kaarniranta K., (2009b) ER stress and hormetic regulation of the aging process. Ageing Res. Rev. 9, 211-217.
127. Salminen A., Kauppinen A., Suuronen T., Kaarniranta K., and, Ojala J., (2009) ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology. J. Neuroinflammation 6, 41.
128. Salminen A., Hyttinen J. M. T., and, Kaarniranta K., (2011) AMP-activated protein kinase inhibits NF-Î?B signaling and inflammation: impact on healthspan and lifespan. J. Mol. Med. 89, 667-676.
129. Sanders M. J., Grondin P. O., Hegarty B. D., Snowden M. A., and, Carling D., (2007) Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J. 403, 139-148. (Pubitemid 46569875)
130. Selman C., Tullet J. M. A., Wieser D., et al. (2009) Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 326, 140-144.
131. Sengupta A., Grundke-Iqbal I., and, Iqbal K., (2006) Regulation of phosphorylation of tau by protein kinases in rat brain. Neurochem. Res. 31, 1473-1480. (Pubitemid 44900588)
132. Shimmyo Y., Kihara T., Akaike A., Niidome T., and, Sugimoto H., (2008a) Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. Biochim. Biophys. Acta 1780, 819-825.
133. Shimmyo Y., Kihara T., Akaike A., Niidome T., and, Sugimoto H., (2008b) Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation. Neuroreport 19, 1329-1333.
134. Signore A. P., Zhang F., Weng Z., Gao Y. Q., and, Chen J., (2008) Leptin neuroprotection in the CNS: mechanisms and therapeutic potentials. J. Neurochem. 106, 1977-1990.
135. Spilman P., Podlutskaya N., Hart M. J., Debnath J., Gorostiza O., Bredesen D., Richardson A., Strong R., and, Galvan V., (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-β levels in a mouse model of Alzheimer's disease. PLoS ONE 5, e9979.
136. Spooren A., Kolmus K., Laureys G., Clinckers R., De Keyser J., Haegeman G., and, Gerlo S., (2011) Interleukin-6, a mental cytokine. Brain Res. Rev. 67, 157-183.
137. Steinberg G. R., and, Kemp B. E., (2009) AMPK in health and disease. Physiol. Rev. 89, 1025-1078.
138. Sun X., He G., Qing H., Zhou W., Dobie F., Cai F., Staufenbiel M., Huang L. E., and, Song W., (2006) Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl Acad. Sci. USA 103, 18727-18732. (Pubitemid 44913478)
139. Swardfager W., Lanctot K., Rothenburg L., Wong A., Cappell J., and, Herrmann N., (2010) A meta-analysis of cytokines in Alzheimer's disease. Biol. Psychiatry 68, 930-941.
140. Swerdlow R. H., Burns J. M., and, Khan S. M., (2010) The Alzheimer's disease mitochondrial cascade hypothesis. J. Alzheimers Dis. 20, S265-S279.
141. Tansley G. H., Burgess B. L., Bryan M. T., et al. (2007) The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of β-amyloid precursor protein. J. Lipid Res. 48, 1022-1034. (Pubitemid 46708669)
142. Terai K., Hiramoto Y., Masaki M., Sugiyama S., Kuroda T., Hori M., Kawase I., and, Hirota H., (2005) AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol. Cell. Biol. 25, 9554-9575. (Pubitemid 41507855)
143. Terunuma M., Vargas K. J., Wilkins M. E., Ramirez O. A., Jaureguiberry-Bravo M., Pangalos M. N., Smart T. G., Moss S. J., and, Couve A., (2010) Prolonged activation of NMDA receptors promotes dephosphorylation and alters postendocytic sorting of GABAB receptors. Proc. Natl Acad. Sci. USA 107, 13918-13923.
144. Tezapsidis N., Johnston J. M., Smith M. A., et al. (2009) Leptin: a novel therapeutic strategy for Alzheimer's disease. J. Alzheimers Dis. 16, 731-740.
145. Thal D. R., Ghebremedhin E., Orantes M., and, Wiestler O. D., (2003) Vascular pathology in Alzheimer's disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J. Neuropathol. Exp. Neurol. 62, 1287-1301. (Pubitemid 37494197)
146. Thornton C., Bright N., Sastre M., Muckett P. J., and, Carling D., (2011) AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid β-peptide exposure. Biochem. J. 434, 503-512.
147. Turdi S., Fan X., Li J., Zhao J., Huff A. F., Du M., and, Ren J., (2010) AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction. Aging Cell 9, 592-606.
148. Turnley A. M., Stapleton D., Mann R. J., Witters L. A., Kemp B. E., and, Bartlett P. F., (1999) Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J. Neurochem. 72, 1707-1716. (Pubitemid 29140848)
149. Une K., Takei Y. A., Tomita N., Asamura T., Ohrui T., Furukawa K., and, Arai H., (2011) Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease. Eur. J. Neurol. 18, 1006-1009.
150. Vangeison G., Carr D., Federoff H. J., and, Rempe D. A., (2008) The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1α in neurons and astrocytes. J. Neurosci. 28, 1988-1993. (Pubitemid 351302661)
151. Vetrivel K. S., and, Thinakaran G., (2010) Membrane rafts in Alzheimer's disease beta-amyloid production. Biochim. Biophys. Acta 1801, 860-867.
152. 2+/calmodulin-dependent protein kinase kinase beta (CaMKKβ) and characterization of CaMKKβ and CaMKKα distribution in the adult mouse brain. Mol. Brain Res. 111, 216-221. (Pubitemid 36332346)
153. Vingtdeux V., Giliberto L., Zhao H., et al. (2010) AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-β peptide metabolism. J. Biol. Chem. 285, 9100-9113.
154. Vingtdeux V., Davies P., Dickson D. W., and, Marambaud P., (2011a) AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies. Acta Neuropathol. 121, 337-349.
155. Vingtdeux V., Chandakkar P., Zhao H., d'Abramo C., Davies P., and, Marambaud P., (2011b) Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradation. FASEB J. 25, 219-231.
156. Viswanathan J., Haapasalo A., Böttcher C., et al. (2011) Alzheimer's disease-associated ubiquilin-1 regulates presenilin-1 accumulation and aggresome formation. Traffic 12, 330-348.
157. Voss M., Paterson J., Kelsall I. R., Martin-Granados C., Hastie C. J.,
158. Wang S., Zhang M., Liang B., Xu J., Xie Z., Liu C., Viollet B., Yan D., and, Zou M. H., (2010) AMPKα2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo. Role of 26S proteasomes. Circ. Res. 106, 1117-1128.
159. Weisova P., Concannon C. G., Devocelle M., Prehn J. H. M., and, Ward M. W., (2009) Regulation of glucose transporter 3 surface expression by the AMP-activated protein kinase mediates tolerance to glutamate excitation in neurons. J. Neurosci. 29, 2997-3008.
160. Won J. S., Im Y. B., Kim J., Singh A. K., and, Singh I., (2010) Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis. Biochem. Biophys. Res. Commun. 399, 487-491.
161. 2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2, 21-33. (Pubitemid 43239822)
162. Wu Y., Song P., Xu J., Zhang M., and, Zou M. H., (2007) Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. J. Biol. Chem. 282, 9777-9788. (Pubitemid 47104626)
163. Xie M., Zhang D., Dyck J. R. B., et al. (2006) A pivotal role for endogenous TGF-β-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc. Natl Acad. Sci. USA 103, 17378-17383. (Pubitemid 44788977)
164. Yang Z., Kahn B. B., Shi H., and, Xue B., (2010) Macrophage α1 AMP-activated protein kinase (α1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J. Biol. Chem. 285, 19051-19059.
165. Yang D. S., Stavrides P., Mohan P. S., et al. (2011) Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. Brain 134, 258-277.
166. Yeung F., Hoberg J. E., Ramsey C. S., Keller M. D., Jones D. R., Frye R. A., and, Mayo M. W., (2004) Modulation of NF-Î?B-dependent transcription and cell survival by the SIRT1 deacetylation. EMBO J. 23, 2369-2380. (Pubitemid 38954844)
167. Yu W. H., Cuervo A. M., Kumar A., et al. (2005) Macroautophagy-a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease. J. Cell Biol. 171, 87-98. (Pubitemid 41434604)
168. Yu J. T., Chang R. C. C., and, Tan L., (2009) Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities. Prog. Neurobiol. 89, 240-255.
169. Zhang X., and, Le W., (2010) Pathological role of hypoxia in Alzheimer's disease. Exp. Neurol. 223, 299-303.
170. Zhang X., Zhou K., Wang R., Cui J., Lipton S. A., Liao F. F., Xu H., and, Zhang Y., (2007) Hypoxia-inducible factor 1α (HIF-1α)-mediated hypoxia increases BACE1 expression and β-amyloid generation. J. Biol. Chem. 282, 10873-10880. (Pubitemid 47100783)
171. Zhang H., Sun S., Herreman A., De Strooper B., and, Bezprozvanny I., (2010a) Role of presenilins in neuronal calcium homeostasis. J. Neurosci. 30, 8566-8580.
172. Zhang Z., Lowry S. F., Guarente L., and, Haimovich B., (2010b) Roles of SIRT1 in the acute and restorative phases following induction of inflammation. J. Biol. Chem. 285, 41391-41401.
173. Zhou G., Sebhat I. K., and, Zhang B. B., (2009a) AMPK activators-potential therapeutics for metabolic and other diseases. Acta Physiol. 196, 175-190.
174. Zhou W., Cao Q., Peng Y., Zhang Q. J., Castrillon D. H., Depinho R. A., and, Liu Z. P., (2009b) FoxO4 inhibits NF-Î?B and protects mice against colonic injury and inflammation. Gastroenterology 137, 1403-1414.
175. Zhu F., and, Qian C., (2006) Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. BMC Neurosci. 7, 78.